FullHope Biomedical Co.,Ltd. (TPEX:7773)
Taiwan · Delayed Price · Currency is TWD 28.05
-0.25 (-0.88%)
At close: May 8, 2026
FullHope Biomedical Market Cap
FullHope Biomedical has a market cap or net worth of 1.12 billion as of May 8, 2026. Its market cap has decreased by -31.42% in one year.
Market Cap
1.12B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.05
Market Cap Chart
Since September 26, 2024, FullHope Biomedical's market cap has decreased from 2.19B to 1.12B, a decrease of -48.91%. That is a compound annual growth rate of -34.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.12B | -8.48% |
| Dec 31, 2025 | 1.22B | -21.71% |
| Dec 31, 2024 | 1.56B | -28.69% |
| Sep 26, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.07B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.53B |
| Uwell Biopharma | 8.45B |
| Intelligene | 7.54B |
| Obigen Pharma | 4.12B |
| BIONET Therapeutics | 2.87B |
| Pet Pharm Biotech | 2.76B |
| Han.biomedical | 683.57M |